Physician

Richard Joseph Steel, M.D.

According to 2025 Medicare claims, Richard Steel, M.D. (NPI: 1679768378) practices internal medicine in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is ALLIANCE IN HEALTH PLLC (NPI: 1821381054; TIN: 273830550) and primary practice location at 78504-2835.

Steel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 89 traditional Medicare patients, billed 3,121 HCPCS/CPT codes, and received $126,405 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,421 prescription claims across 279 beneficiaries totaling $1,200,954 in drug costs, led by Ozempic (Semaglutide). DME data shows 61 claims. Open Payments data shows 8 records totaling $341. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $329,726 to $126,405. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $793,142 to $1,200,954. For DME billing, this smaller-volume category moved from a lower plateau to a higher plateau, from $6,254 to $19,253.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	244	9,541	$329,726
2016	237	9,810	$365,357
2017	252	8,772	$374,155
2018	231	11,293	$447,667
2019	241	11,416	$489,426
2020	208	12,295	$372,335
2021	185	6,192	$345,264
2022	153	4,371	$258,004
2023	114	3,059	$194,341
2024	89	3,121	$126,405

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	230	5,050	$793,142
2016	226	5,330	$829,483
2017	274	5,564	$923,968
2018	289	6,443	$1,127,791
2019	321	7,592	$1,411,475
2020	321	7,752	$1,593,470
2021	323	6,928	$1,586,427
2022	320	6,858	$1,602,207
2023	285	5,910	$1,524,820
2024	279	5,421	$1,200,954

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	267	532	$13,562
2016	207	481	$10,392
2017	146	275	$8,785
2018	169	338	$7,912
2019	221	540	$12,999
2020	161	476	$8,354
2021	83	286	$9,722
2022	48	281	$17,590
2023	19	99	$9,196
2024	13	61	$8,630

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	87	640	$84
99497	Advance care planning, first 30 minutes	64	67	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	58	116	$62
99498	Advance care planning, each additional 30 minutes	64	67	$56
36415	Insertion of needle into vein for collection of blood sample	74	184	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	166	8,086	$257,017
Mounjaro	Tirzepatide	130	5,002	$183,098
Trulicity	Dulaglutide	92	4,822	$156,144
Rybelsus	Semaglutide	22	1,620	$49,555
Tradjenta	Linagliptin	34	2,880	$47,463

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	24	$8,197
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	26	$417
A4259	Lancets, per box of 100	N	N/R	11	$16

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$341	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Joseph Steel, M.D.?

Tedicare shows public-source Medicare data for Richard Joseph Steel, M.D. (NPI 1679768378), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Joseph Steel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Joseph Steel, M.D.?

Richard Joseph Steel, M.D. is linked to ALLIANCE IN HEALTH PLLC (billing NPI 1821381054) in the available physician profile data.

Does Richard Joseph Steel, M.D. have Open Payments data?

Richard Joseph Steel, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.